Procedural characteristics and their association with vital status during follow-up
| Characteristics | Survivors n=566 (92%) | Cardiac deaths n=25 (4.1%) | Non-cardiac deaths n=21 (3.4%) | p Value |
| Extension of CAD | ||||
| 1-Vessel | 305 (54) | 10 (40) | 11 (52) | 0.081 |
| 2-Vessel | 191 (34) | 7 (28) | 7 (33) | |
| 3-Vessel | 69 (12) | 8 (32) | 3 (14) | |
| No. of vessels treated | 1.6±0.8 | 1.8±0.9 | 1.5±0.7 | NS |
| No. of lesions treated | 1.8±0.9 | 2.2±1.4 | 1.6±0.7 | 0.041 |
| Use of stent | 525 (93) | 25 (100) | 19 (90) | NS |
| Use of DES | 73 (13) | 4 (16) | 3 (14) | NS |
| No. of stents | 1.6±0.8 | 1.8±1.0 | 1.6±0.8 | NS |
| Peak CK-MB | ||||
| <UNL | 438 (77) | 12 (48) | 18 (86) | |
| 1–3×UNL | 106 (19) | 11 (44) | 3 (14) | 0.012 |
| >3×UNL | 22 (4) | 2 (8) | 0 | |
Results are shown as mean±SD or number (%).
CAD, coronary artery disease; CK-MB, creatine kinase-MB; DES, drug-eluting stents; UNL, upper normal limit.